RESUMO
Mismatches between skin pigmentation and modern lifestyle continue to challenge our naked skin. One of our responses to these challenges is the development and use of sunscreens. The management of sunscreens has to balance their protective effect against erythema, photocarcinogenesis and photoageing owing to the potential toxicity of the ultraviolet (UV) filters for humans and the environment. The protection against UV radiation offered by sunscreens was recently standardized in the European Union (EU) based on international harmonization of measurement techniques. Four different categories of sun protection have been implemented along with recommendations on how to use sunscreen products in order to obtain the labelled protection. The UV filters in sunscreens have long been authorized for use by the EU authority on the basis of data from studies on acute toxicity, subchronic and chronic toxicity, reproductive toxicity, genotoxicity, photogenotoxicity, carcinogenicity, irritation, sensitization, phototoxicity and photosensitization as well as on environmental aspects. New challenges with respect to the safety of UV filters have arisen from the banning of animal experiments for the development of cosmetics. Future debates on sunscreens are likely to focus on nanoparticles and environmental issues, along with motivation campaigns to persuade consumers to protect their skin. However, more efficient sunscreen use will also continue to raise questions on the benefit in preventing vitamin D synthesis in the skin induced by sunlight.
Assuntos
Queimadura Solar/prevenção & controle , Protetores Solares/efeitos adversos , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/prevenção & controle , Rotulagem de Medicamentos/legislação & jurisprudência , Monitoramento de Medicamentos , Poluição Ambiental/prevenção & controle , Humanos , Ceratose Actínica/induzido quimicamente , Ceratose Actínica/prevenção & controle , Legislação de Medicamentos , Estilo de Vida , Melanoma/induzido quimicamente , Melanoma/prevenção & controle , Cooperação do Paciente , Educação de Pacientes como Assunto , Neoplasias Cutâneas/induzido quimicamente , Neoplasias Cutâneas/prevenção & controle , Protetores Solares/normas , Resultado do Tratamento , Vitamina D/antagonistas & inibidoresRESUMO
Stimulating rat thyroid FRTL-5 cells with the purinergic agonist ATP activates both the inositol phosphate signal-transduction pathway and the phospholipase A2 pathway. In the present study we wanted to investigate the possible inter-relationships between these two systems during ATP-induced changes in intracellular free calcium ([Ca2+]i). Pretreatment of Fura-2 loaded cells with 4-bromophenylacyl, an inhibitor of phospholipase A2, had no effect on the ATP-induced entry of Ca2+ but inhibited the release of sequestered Ca2+. Nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor, and 5,8,11,14-eicosatetraynoic acid (ETYA), an inhibitor of cytochrome P-450 enzymes, attenuated the ATP-evoked transient increase in [Ca2+]i. Furthermore, the capacitative entry of Ca2+ was also attenuated in NDGA- and ETYA-treated cells stimulated with ATP. Similar results were obtained using econazole, an inhibitor of cytochrome P-450 enzymes. However, treatment of the cells with indomethacin, a cyclooxygenase inhibitor, had no effect on the ATP-evoked response in [Ca2+]i. We also showed that stimulation of intact or permeabilized FRTL-5 cells with arachidonic acid released sequestered calcium. This calcium originated, at least in part, from an IP3 sensitive calcium pool. In addition, arachidonic acid rapidly acidified the cytosol. The results suggest that metabolism of arachidonic acid by a non-cyclooxygenase pathway is of importance in supporting agonist-induced calcium fluxes evoked via stimulation of the inositol phosphate pathway in FRTL-5 cells. Furthermore, arachidonic acid per se may modify agonist-induced calcium fluxes in these cells.
Assuntos
Trifosfato de Adenosina/farmacologia , Ácido Araquidônico/metabolismo , Cálcio/metabolismo , Fosfatos de Inositol/metabolismo , Fosfolipases A/metabolismo , Glândula Tireoide/metabolismo , Ácido 5,8,11,14-Eicosatetrainoico/farmacologia , Trifosfato de Adenosina/antagonistas & inibidores , Animais , Ácido Araquidônico/farmacologia , Linhagem Celular , Econazol/farmacologia , Masoprocol/farmacologia , Fosfolipases A/antagonistas & inibidores , Fosfolipases A2 , Ratos , Transdução de Sinais , Glândula Tireoide/citologiaRESUMO
Succinate:quinone reductase catalyzes electron transfer from succinate to quinone in aerobic respiration. Carboxin is a specific inhibitor of this enzyme from several different organisms. We have isolated mutant strains of the bacterium Paracoccus denitrificans that are resistant to carboxin due to mutations in the succinate:quinone reductase. The mutations identify two amino acid residues, His228 in SdhB and Asp89 in SdhD, that most likely constitute part of a carboxin-binding site. This site is in the same region of the enzyme as the proposed active site for ubiquinone reduction. From the combined mutant data and structural information derived from Escherichia coli and Wolinella succinogenes quinol:fumarate reductase, we suggest that carboxin acts by blocking binding of ubiquinone to the active site. The block would be either by direct exclusion of ubiquinone from the active site or by occlusion of a pore that leads to the active site.
Assuntos
Carboxina/metabolismo , Complexos Multienzimáticos/genética , Complexos Multienzimáticos/metabolismo , Mutação , Oxirredutases/genética , Oxirredutases/metabolismo , Paracoccus denitrificans/enzimologia , Paracoccus denitrificans/genética , Succinato Desidrogenase/genética , Succinato Desidrogenase/metabolismo , Sequência de Aminoácidos , Sequência de Bases , Sítios de Ligação/genética , Carboxina/farmacologia , DNA Bacteriano/genética , Farmacorresistência Bacteriana/genética , Complexo II de Transporte de Elétrons , Inibidores Enzimáticos/metabolismo , Inibidores Enzimáticos/farmacologia , Escherichia coli/enzimologia , Genes Bacterianos , Modelos Moleculares , Dados de Sequência Molecular , Complexos Multienzimáticos/antagonistas & inibidores , Complexos Multienzimáticos/química , Oxirredutases/antagonistas & inibidores , Oxirredutases/química , Paracoccus denitrificans/efeitos dos fármacos , Conformação Proteica , Homologia de Sequência de Aminoácidos , Succinato Desidrogenase/antagonistas & inibidores , Succinato Desidrogenase/químicaRESUMO
Succinate:quinone reductase is a membrane-bound enzyme of the citric acid cycle and the respiratory chain. Carboxin is a potent inhibitor of the enzyme of certain organisms. The bacterium Paracoccus denitrificans was found to be sensitive to carboxin in vivo, and mutants that grow in the presence of 3'-methyl carboxin were isolated. Membranes of the mutants showed resistant succinate:quinone reductase activity. The mutation conferring carboxin resistance was identified in four mutants. They contained the same missense mutation in the sdhD gene, which encodes one of two membrane-intrinsic polypeptides of the succinate:quinone reductase complex. The mutation causes an Asp to Gly replacement at position 89 in the SdhD polypeptide. P. denitrificans strains that overproduced wild-type or mutant enzymes were constructed. Enzymic properties of the purified enzymes were analyzed. The apparent Km for quinone (DPB) and the sensitivity to thenoyltrifluoroacetone was normal for the carboxin-resistant enzyme, but the succinate:quinone reductase activity was lower than for the wild-type enzyme. Mutations conferring carboxin resistance indicate the region on the enzyme where the inhibitor binds. A previously reported His to Leu replacement close to the [3Fe-4S] cluster in the iron-sulfur protein of Ustilago maydis succinate:quinone reductase confers resistance to carboxin and thenoyltrifluoroacetone. The Asp to Gly replacement in the P. denitrificans SdhD polypeptide, identified in this study to confer resistance to carboxin but not to thenoyltrifluoroacetone, is in a predicted cytoplasmic loop connecting two transmembrane segments. It is likely that this loop is located in the neighborhood of the [3Fe-4S] cluster.
Assuntos
Complexos Multienzimáticos/genética , Oxirredutases/genética , Paracoccus denitrificans/enzimologia , Paracoccus denitrificans/genética , Succinato Desidrogenase/genética , Carboxina/farmacologia , Ciclo do Ácido Cítrico/fisiologia , Resistência Microbiana a Medicamentos , Complexo II de Transporte de Elétrons , Eletroforese em Gel de Poliacrilamida , Fungicidas Industriais/farmacologia , Genes Bacterianos/genética , Complexos Multienzimáticos/antagonistas & inibidores , Mutagênese Sítio-Dirigida , Oxirredutases/antagonistas & inibidores , Paracoccus denitrificans/efeitos dos fármacos , Paracoccus denitrificans/crescimento & desenvolvimento , Succinato Desidrogenase/antagonistas & inibidores , Tenoiltrifluoracetona/farmacologia , Fatores de TempoRESUMO
Succinate:quinone reductases are membrane-bound enzymes that catalyze electron transfer from succinate to quinone. Some enzymes in vivo reduce ubiquinone (exergonic reaction) whereas others reduce menaquinone (endergonic reaction). The succinate:menaquinone reductases all contain two heme groups in the membrane anchor of the enzyme: a proximal heme (heme b(P)) located close to the negative side of the membrane and a distal heme (heme b(D)) located close to the positive side of the membrane. Heme b(D) is a distinctive feature of the succinate:menaquinone reductases, but the role of this heme in electron transfer to quinone has not previously been analyzed. His28 and His113 are the axial ligands to heme b(D) in Bacillus subtilis succinate:menaquinone reductase. We have individually replaced these His residues with Leu and Met, respectively, resulting in assembled membrane-bound enzymes. The H28L mutant enzyme lacks succinate:quinone reductase activity probably due to a defective quinone binding site. The H113M mutant enzyme contains heme b(D) with raised midpoint potential and is impaired in electron transfer to menaquinone. Our combined experimental data show that the heme b(D) center, into which we include a quinone binding site, is crucial for succinate:menaquinone reductase activity. The results support a model in which menaquinone is reduced on the positive side of the membrane and the transmembrane electrochemical potential provides driving force for electron transfer from succinate via heme b(P) and heme b(D) to menaquinone.
Assuntos
Bacillus subtilis/enzimologia , Complexos Multienzimáticos/química , Complexos Multienzimáticos/metabolismo , Oxirredutases/química , Oxirredutases/metabolismo , Succinato Desidrogenase/química , Succinato Desidrogenase/metabolismo , Bacillus subtilis/genética , Sequência de Bases , Sítios de Ligação/genética , Primers do DNA/genética , Transporte de Elétrons , Complexo II de Transporte de Elétrons , Heme/química , Cinética , Modelos Moleculares , Complexos Multienzimáticos/genética , Mutagênese Sítio-Dirigida , Oxirredutases/genética , Espectrofotometria , Especificidade por Substrato , Succinato Desidrogenase/genética , Vitamina K/química , Vitamina K/metabolismoRESUMO
Electron paramagnetic resonance (EPR) studies of succinate:ubiquinone oxidoreductase (SQR) from Paracoccus denitrificans have been undertaken in the purified and membrane-bound states. Spectroscopic "signatures" accounting for the three iron-sulfur clusters (2Fe-2S, 3Fe-4S, and 4Fe-4S), cytochrome b, flavin, and protein-bound ubisemiquinone radicals have been obtained in air-oxidized, succinate-reduced, and dithionite-reduced preparations at 4-10 K. Spectra obtained at 170 K in the presence of excess succinate showed a signal typical of that of a flavin radical, but superimposed with another signal. The superimposed signal originated from two bound ubisemiquinones, as shown by spectral simulations. Power saturation measurements performed on the air-oxidized enzyme provided evidence for a weak magnetic dipolar interaction operating between the oxidized 3Fe-4S cluster and the oxidized cytochrome b. Power saturation experiments performed on the succinate- and dithionite-reduced forms of the enzyme demonstrated that the 4Fe-4S cluster is coupled weakly to both the 2Fe-2S and the 3Fe-4S clusters. Quantitative interpretation of these power saturation experiments has been achieved through redox calculations. They revealed that a spin-spin interaction between the reduced 3Fe-4S cluster and the cytochrome b (oxidized) may also exist. These findings form the first direct EPR evidence for a close proximity (=2 nm) of the high potential 3Fe-4S cluster, situated in the succinate dehydrogenase part of the enzyme, and the low potential, low spin b-heme in the membrane anchor of the enzyme.